Jinekolojik Kanserler
Özet
Referanslar
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians; 2018. 68(6), 394-424. doi.org/10.3322/caac.21492
Öztürk ENY, Uyar M. Globocan 2012 ve 2018 verileri üzerinden Dünya’da, Avrupa’da ve Türkiye’de en sık görülen beş kanser türünün değerlendirilmesi. Sakarya Üniversitesi Holistik Sağlık Dergisi; 2021. 4(1), 17-27.
McCluggage WG, Bosse T, Gilks CB, et al. FIGO 2023 endometrial cancer staging: too much, too soon? International Journal of Gynecologic Cancer; 2024. 34(1). doi.org/10.1136/ijgc-2023-004981
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet; 2009. 105: 103-104
Sheikh MA, Althouse AD, Freese KE, et al. USA endometrial cancer projections to 2030: should we be concerned? Future oncology; 2014. 10(16), 2561-2568. doi.org/10.2217/fon.14.192
Solmaz U, Ekin A, Mat E, et al. Endometriyum Kanserinde Güncel Yaklaşımlar. Türk Jinekolojik Onkoloji Dergisi; 2016. 19(1), 7-16.
Purdie DM, Green AC. Epidemiology of endometrial cancer. Best practice & research Clinical obstetrics & gynaecology, 2001.15(3), 341-354. doi.org/10.1053/beog.2000.0180
Sheikh MA, Althouse AD, Freese KE, et al. USA endometrial cancer projections to 2030: should we be concerned?. Future oncology; 2014. 10(16), 2561-2568. doi.org/10.2217/fon.14.192
Balkaya NA, Bilge Ç, Dönmez S. İşbirlikli Öğrenme ve İnteraktif Eğitim Yöntemlerinin Hemşirelik Öğrencilerinin Motivasyon ve Özgüvenlerine Etkisi. Kadın Sağlığı Hemşireliği Dergisi; 2022. 8(1), 14-24.
Güngördük K. Endometrium Kanseri In: Yıldırım G. (ed.) Williams Jinekoloji. İstanbul: Nobel Tıp Kitabevleri Tic. Ltd. Şti.; 2015. p. 817-838.
Kuzhan A. The Prognostic Factors in Endometrial Cancers Treated with Radiotherapy: Retrospective Analysis. Acta Oncologica Turcica;2023. 56(3), 190-197. 10.5505/aot.2023.02779
Backes FJ, Brudie, LA, Farrell MR, et al. Short-and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecologic oncology; 2012. 125(3), 546-551. doi.org/10.1016/j.ygyno.2012.02.023
Aslan E., Aslan D.F. Jinekolojik Kanserler ve BakımŞahin NH (ed.) In: Kadın Sağlığı Hastalıkları ve Doğum. 2023. p 480-485
Kose M, Hitit M, Kaya MS, et al. Expression pattern of microRNAs in ovine endometrium during the peri-implantation. Theriogenology; 2022. 191, 35-46.
Erdoğan EN, Güvenç G, İyigün E. Orem’in Öz Bakım Eksikliği Hemşirelik Teorisi’ne Göre Over Kanseri Nedeniyle Ameliyat Olan Hastanın Hemşirelik Bakımı: Olgu Sunumu. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi; 2023. 6(3), 749-758. doi.org/10.38108/ouhcd.1217572
Cabasag CJ, Fagan PJ, Ferlay J, et al. Soerjomataram, I. Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. Int. J.Cancer; 2022.151, 1535–1541 doi.org/10.38108/ouhcd.1217572
Bristow RE, Chang J, Ziogas A, et al. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. Journal of the american college of surgeons; 2015. 220(5), 940-950.doi.org/10.1016/j.jamcollsurg.2015.01.056
Armstrong, DK, Alvarez RD, Bakkum-Gamez JN, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network; 2021.19(2), 191-226. doi.org/10.6004/jnccn.2021.0007
Menon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. The Lancet, 397(10290); 2021. 2182-2193. doi.org/10.1016/S0140-6736(21)00731-5
Michels KA, Pfeiffer RM, Brinton LA, et al. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA oncology; 2018. 4(4), 516-521. doi:10.1001/jamaoncol.2017.4942
Güzel D, Yıldırım N, Besler A, et al. (). Over kanserinin epidemiyolojisi ve genel sağ kalım özellikleri. Ege Tıp Dergisi; 2019; 44-49.
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. International journal of cancer; 2021. 149(4), 778-789. https://doi.org/10.1002/ijc.33588
Balat Ö, Franklin CL, Edwards CL Over Kanserindeki Klasik ve Yeni Tanı Yöntemleri. Journal of Clinical Obstetrics & Gynecology; 1996. 6(4), 345-348.
Sokalska A, Timmerman D, Testa AC, et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology; 2009.34(4), 462-470.
Afşin Y, Kamalak, Z, Ekinci A. Over Kanserinde Güncel Yaklaşımlar ve Tedavi Yöntemlerinin Değerlendirilmesi. Ankara: İksad Yayınevi; 2022.
Barani M, Bilal M, Sabir F, et al. Nanotechnology in ovarian cancer: Diagnosis and treatment. Life Sciences; 2021. 266, 118914. doi.org/10.1016/j.lfs.2020.118914
Coşan Terek M, Taylan E, Akman L, et al. Erken Evre Over Kanserlerinde Prognoz ve Standart Tedavi Uygulamaları. Türk Jinekolojik Onkoloji Dergisi; 2013.16(3).
Sağlık Bakanlığı. Halk Sağlığı Genel Müdürlüğü Kanser Dairesi Başkanlığı. Türkiye Kanser İstatikleri (2017). Kanser rapor 2017 (https://hsgm.saglik.gov.tr/depo/birimler/kanserdb/istatistik/Turkiye_Kanser_Istatistikleri_2017.pdf). Erişim tarihi:10 Mart 2024
Görgülü G, Sancı M. Proflaktik Salpingo-Ooforektomi Yapılan Ailevi Meme Ve Over Kanser Sendromlu Hastalarda Klinik Bulgular Farklı Mıdır?. Kocatepe Tıp Dergisi; 2023.24(1), 57-61. doi.org/10.18229/kocatepetip.991496
Kyrgiou M, Salanti G, Pavlidis N, et al. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. Journal of the National Cancer Institute; 2006. 98(22), 1655-1663. doi.org/10.1093/jnci/djj443
Yahara K, Ohguri T, Imada H, et al. Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy. J Radiat Res; 2013. 54(2): p. 322-9. doi.org/10.1093/jrr/rrs108
Özkan S, Serçekuş P, Alataş E. Jinekolojik onkolojide bakım. 1.Baskı, Ankara: Akademisyen Kitapevi; 2022. s. 169-177, 287-307.
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. International journal of cancer; 2021.149(4), 778-789. doi.org/10.1002/ijc.33588
Engelberth SA, Hempel N, Bergkvıst M. (). Development of Nanoscale Approaches for Ovarian Cancer Therapeutics and Diagnostics. Critical Reviews™ in Oncogenesis; 2014. 19(3-4):281-315
Zahedı P, Yoganathan R, Pıquette-Mıller M, et al. Recent advances in drug delivery strategies for treatment of ovarian cancer. Expert Opinin Drug Delivery; 2012.9(5): 567-583 doi.org/10.1517/17425247.2012.665366
Erdoğan EN, Güvenç G, İyigün, E. Orem’in Öz Bakım Eksikliği Hemşirelik Teorisi’ne Göre Over Kanseri Nedeniyle Ameliyat Olan Hastanın Hemşirelik Bakımı: Olgu Sunumu. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi; 2023. 6(3), 749-758. doi.org/10.38108/ouhcd.1217572
Islami F, Guerra CE, Minihan A, et al. American Cancer Society's report on the status of cancer disparities in the United States, 2021. CA: a cancer journal for clinicians; 2022.72(2), 112-143. doi.org/10.3322/caac.21703
Nalbantoğlu HG, Arslan P. Servikal kanser: Genel bakış. Karatekin University Journal of Science; 2023. 2(1), 43-50.
Grau-Bejar JF, Garcia-Duran C, Garcia-Illescas D, et al. (). Advances in immunotherapy for cervical cancer. Therapeutic Advances in Medical Oncology; 2023.15, doi.org/10.1177/175883592311638
Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer biology & medicine;2020.17(4), 864.
Aydoğdu SGM, Özsoy Ü. Serviks kanseri ve HPV. Androl Bul; 2018.(20):25−29.
Aref‐Adib M, Freeman‐Wang T. Cervical cancer prevention and screening: the role of human papillomavirus testing. Obstetrician & Gynaecologist; 2016.18(4). doi.org/10.1111/tog.12279
Avcı G, Bozdayı G. İnsan papilloma virüsü. Kafkas J Med Sci;2013. 3:136–44. doi.org/10.5505/kjms.2013.52724
Uyan DD, Başer DA, Sarı E, et al. Tıp fakültesi öğrencilerinin servikal kanser hakkında bilgi düzeyleri ve Human Papilloma Virus aşısına karşı tutumları. The Journal of Turkish Family Physician, 2021.12(2), 66-75.doi: 10.15511/tjtfp.21.00266
Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. The lancet global health; 2023.11(2), e197-e206. doi.org/10.1016/S2214-109X(22)00501-0
Rahangdale L, Mungo C, O’Connor S, Chibwesha CJ, et al. Human papillomavirus vaccination and cervical cancer risk. Bmj; 2022. 379. doi.org/10.1136/bmj-2022-070115
Eryılmaz G. Preinvaziv Serviks Kanseri. In: Yıldırım G (ed.) Jinekolojik Kanserler Güncel Konular ve Bakım. Ankara Nobel Tıp Kitabevleri: 2023; p172-174
Deo SVS, Sharma J, Kumar S. GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists. Annals of surgical oncology; 2022.29(11), 6497-6500. doi.org/10.1245/s10434-022-12151-6
Diniz ND, Rezende, MT, Bianchi, AGC, et al. A deep learning ensemble method to assist cytopathologists in pap test image classification. Journal of Imaging, 2021, 7.7: 111. doi.org/10.3390/jimaging7070111
Bedell SL, Goldstein LS, Goldstein AR, et al. Cervical cancer screening: past, present, and future. Sexual medicine reviews; 2020. 8(1), 28-37 doi.org/10.1016/j.sxmr.2019.09.005
Dede M. Profilaktik HPV aşıları: güncel yaklaşımlar. Gülhane Tıp Dergisi;2010. 52(2), 148-56.
Ngoma M, Autier P. Cancer prevention: cervical cancer. Ecancermedicalscience; 2019. 13. doi: 10.3332/ecancer.2019.952
Yang J, Delara R, Magrina J, et al. Management and outcomes of primary vaginal Cancer. Gynecologic oncology; 2020.159(2), 456-463. doi.org/10.1016/j.ygyno.2020.08.036
Yılmaz E, Coşkun Eİ, Taşkıran Ç. Gebelik ve Jinekolojik Kanserler. Türk Jinekolojik Onkoloji Dergisi; 2016.19(2), 19-28.
Adams TS, Rogers LJ, Cuello MA. (). Cancer of the vagina: 2021 update. International Journal of Gynecology & Obstetrics; 2021.155, 19-27. doi.org/10.1002/ijgo.13867
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians; 2018. 68(6), 394-424. https://doi.org/10.3322/caac.21492
Adams TS, Cuello MA. Cancer of the vagina. International Journal of Gynecology & Obstetrics; 2018. 143, 14-21. https://doi.org/10.1002/ijgo.12610
Adhikari P, Vietje P, Mount S. Premalignant and malignant lesions of the vagina. Diagn Histopathol; 2016.23:28-34. doi.org/10.1016/j.mpdhp.2016.11.006
Jhingran A. Updates in the treatment of vaginal cancer. International Journal of Gynecologic Cancer; 2022.32(3). doi.org/10.1136/ijgc-2021-002517
DeSantis C, Siegal R, Ma J, et al. Cancer treatment and survivorship statistics. American Cancer Society. CA Cancer J Clinic; 2018. 64, 252–27 https://doi.org/10.3322/caac.21235
Işık EG. PET/CT Imaging in Patients with Vulvar and Vaginal Cancer. Nukleer Tıp Seminerleri; 2022 8(3), 182. doi:10.4274/nts.galenos.2022.0021
Keskin HG, Tahta T. Vulva kanseri ve vulvektomi sonrası hemşirelik yaklaşımları. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2021. 5(1), 115-121. doi.org/10.46237/amusbfd.725542
Alkatout I, Schubert M, Garbrecht N, et al. Vulvar cancer: epidemiology, clinical presentation, and management options. International journal of women's health; 2015. 305-313.
Şirin A. Kavlak O. Kadın Sağlığı (2nd ed.). İstanbul: Nobel Tıp Kitabevleri; 2015.
Tagliaferri L, Lancellotta V, Casà C, et al. The radiotherapy role in the multidisciplinary management of locally advanced vulvar cancer: a multidisciplinary VulCan team review. Cancers; 2021.13(22), 5747. doi.org/10.3390/cancers13225747
Rahm C, Adok C, Dahm-Kähler P, et al. Complications and risk factors in vulvar cancer surgery–A population-based study. European Journal of Surgical Oncology; 2022. 48(6), 1400-1406. doi.org/10.1016/j.ejso.2022.02.006
Demirtaş GS, Dinçer F, Görgülü G, et al. Prognostic factors in vulvar cancer patients: a single center experience. Pamukkale Medical Journal; 2021.14(4), 900-907. doi.org/10.31362/patd.978808
Aydın Ç, Göl M, Baloğlu A, e al. Vulva Kanseri Nedeniyle Radikal Vulvektomi Uygulanan Hastalarin Değerlendirilmesi. Ege Tıp Dergisi; 2002. 41(3), 147-150.
Agabekova B, Özler NB, Luboteni R. HPV İlişkili Kanserlere Karşı Mücdelede HPV Aşıları Hakkında Derleme. Turkey Health Literacy Journal; 2021.2(2), 89-98. Doi:10.54247/SOYD.2021.29
Akalın A. Human Papillomavirus (HPV) Enfeksiyonu ve HPV aşısında güncel yaklaşımlar. Androloji Bülteni; 2022. 24(2). doi.org/10.24898/tandro.2022.25993
Dursun P, Kaya D, Kuscu E, et al. Tubal Transizyonel Hücreli Karsinom. Türk Jinekolojik Onkoloji Dergisi;2007. 10(1), 26-28.
Suh MJ, Lee S, H, Kım et al. A case of primary tubal cancer evaluated with laparoscopy. Korean Journal of Obstetrics and Gynecology;2006. 1364-1370.
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2024. Available from: https://gco.iarc.who.int/today, accessed [15 Nisan 2024]
Berek JS, Matias‐Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. International Journal of Gynecology & Obstetrics;2023. 162(2), 383-394. https://doi.org/10.1002/ijgo.14923
Referanslar
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians; 2018. 68(6), 394-424. doi.org/10.3322/caac.21492
Öztürk ENY, Uyar M. Globocan 2012 ve 2018 verileri üzerinden Dünya’da, Avrupa’da ve Türkiye’de en sık görülen beş kanser türünün değerlendirilmesi. Sakarya Üniversitesi Holistik Sağlık Dergisi; 2021. 4(1), 17-27.
McCluggage WG, Bosse T, Gilks CB, et al. FIGO 2023 endometrial cancer staging: too much, too soon? International Journal of Gynecologic Cancer; 2024. 34(1). doi.org/10.1136/ijgc-2023-004981
Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet; 2009. 105: 103-104
Sheikh MA, Althouse AD, Freese KE, et al. USA endometrial cancer projections to 2030: should we be concerned? Future oncology; 2014. 10(16), 2561-2568. doi.org/10.2217/fon.14.192
Solmaz U, Ekin A, Mat E, et al. Endometriyum Kanserinde Güncel Yaklaşımlar. Türk Jinekolojik Onkoloji Dergisi; 2016. 19(1), 7-16.
Purdie DM, Green AC. Epidemiology of endometrial cancer. Best practice & research Clinical obstetrics & gynaecology, 2001.15(3), 341-354. doi.org/10.1053/beog.2000.0180
Sheikh MA, Althouse AD, Freese KE, et al. USA endometrial cancer projections to 2030: should we be concerned?. Future oncology; 2014. 10(16), 2561-2568. doi.org/10.2217/fon.14.192
Balkaya NA, Bilge Ç, Dönmez S. İşbirlikli Öğrenme ve İnteraktif Eğitim Yöntemlerinin Hemşirelik Öğrencilerinin Motivasyon ve Özgüvenlerine Etkisi. Kadın Sağlığı Hemşireliği Dergisi; 2022. 8(1), 14-24.
Güngördük K. Endometrium Kanseri In: Yıldırım G. (ed.) Williams Jinekoloji. İstanbul: Nobel Tıp Kitabevleri Tic. Ltd. Şti.; 2015. p. 817-838.
Kuzhan A. The Prognostic Factors in Endometrial Cancers Treated with Radiotherapy: Retrospective Analysis. Acta Oncologica Turcica;2023. 56(3), 190-197. 10.5505/aot.2023.02779
Backes FJ, Brudie, LA, Farrell MR, et al. Short-and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer staging. Gynecologic oncology; 2012. 125(3), 546-551. doi.org/10.1016/j.ygyno.2012.02.023
Aslan E., Aslan D.F. Jinekolojik Kanserler ve BakımŞahin NH (ed.) In: Kadın Sağlığı Hastalıkları ve Doğum. 2023. p 480-485
Kose M, Hitit M, Kaya MS, et al. Expression pattern of microRNAs in ovine endometrium during the peri-implantation. Theriogenology; 2022. 191, 35-46.
Erdoğan EN, Güvenç G, İyigün E. Orem’in Öz Bakım Eksikliği Hemşirelik Teorisi’ne Göre Over Kanseri Nedeniyle Ameliyat Olan Hastanın Hemşirelik Bakımı: Olgu Sunumu. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi; 2023. 6(3), 749-758. doi.org/10.38108/ouhcd.1217572
Cabasag CJ, Fagan PJ, Ferlay J, et al. Soerjomataram, I. Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020. Int. J.Cancer; 2022.151, 1535–1541 doi.org/10.38108/ouhcd.1217572
Bristow RE, Chang J, Ziogas A, et al. Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival. Journal of the american college of surgeons; 2015. 220(5), 940-950.doi.org/10.1016/j.jamcollsurg.2015.01.056
Armstrong, DK, Alvarez RD, Bakkum-Gamez JN, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network; 2021.19(2), 191-226. doi.org/10.6004/jnccn.2021.0007
Menon U, Gentry-Maharaj A, Burnell M, et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. The Lancet, 397(10290); 2021. 2182-2193. doi.org/10.1016/S0140-6736(21)00731-5
Michels KA, Pfeiffer RM, Brinton LA, et al. Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers. JAMA oncology; 2018. 4(4), 516-521. doi:10.1001/jamaoncol.2017.4942
Güzel D, Yıldırım N, Besler A, et al. (). Over kanserinin epidemiyolojisi ve genel sağ kalım özellikleri. Ege Tıp Dergisi; 2019; 44-49.
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. International journal of cancer; 2021. 149(4), 778-789. https://doi.org/10.1002/ijc.33588
Balat Ö, Franklin CL, Edwards CL Over Kanserindeki Klasik ve Yeni Tanı Yöntemleri. Journal of Clinical Obstetrics & Gynecology; 1996. 6(4), 345-348.
Sokalska A, Timmerman D, Testa AC, et al. Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology; 2009.34(4), 462-470.
Afşin Y, Kamalak, Z, Ekinci A. Over Kanserinde Güncel Yaklaşımlar ve Tedavi Yöntemlerinin Değerlendirilmesi. Ankara: İksad Yayınevi; 2022.
Barani M, Bilal M, Sabir F, et al. Nanotechnology in ovarian cancer: Diagnosis and treatment. Life Sciences; 2021. 266, 118914. doi.org/10.1016/j.lfs.2020.118914
Coşan Terek M, Taylan E, Akman L, et al. Erken Evre Over Kanserlerinde Prognoz ve Standart Tedavi Uygulamaları. Türk Jinekolojik Onkoloji Dergisi; 2013.16(3).
Sağlık Bakanlığı. Halk Sağlığı Genel Müdürlüğü Kanser Dairesi Başkanlığı. Türkiye Kanser İstatikleri (2017). Kanser rapor 2017 (https://hsgm.saglik.gov.tr/depo/birimler/kanserdb/istatistik/Turkiye_Kanser_Istatistikleri_2017.pdf). Erişim tarihi:10 Mart 2024
Görgülü G, Sancı M. Proflaktik Salpingo-Ooforektomi Yapılan Ailevi Meme Ve Over Kanser Sendromlu Hastalarda Klinik Bulgular Farklı Mıdır?. Kocatepe Tıp Dergisi; 2023.24(1), 57-61. doi.org/10.18229/kocatepetip.991496
Kyrgiou M, Salanti G, Pavlidis N, et al. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments. Journal of the National Cancer Institute; 2006. 98(22), 1655-1663. doi.org/10.1093/jnci/djj443
Yahara K, Ohguri T, Imada H, et al. Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy. J Radiat Res; 2013. 54(2): p. 322-9. doi.org/10.1093/jrr/rrs108
Özkan S, Serçekuş P, Alataş E. Jinekolojik onkolojide bakım. 1.Baskı, Ankara: Akademisyen Kitapevi; 2022. s. 169-177, 287-307.
Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: An overview. International journal of cancer; 2021.149(4), 778-789. doi.org/10.1002/ijc.33588
Engelberth SA, Hempel N, Bergkvıst M. (). Development of Nanoscale Approaches for Ovarian Cancer Therapeutics and Diagnostics. Critical Reviews™ in Oncogenesis; 2014. 19(3-4):281-315
Zahedı P, Yoganathan R, Pıquette-Mıller M, et al. Recent advances in drug delivery strategies for treatment of ovarian cancer. Expert Opinin Drug Delivery; 2012.9(5): 567-583 doi.org/10.1517/17425247.2012.665366
Erdoğan EN, Güvenç G, İyigün, E. Orem’in Öz Bakım Eksikliği Hemşirelik Teorisi’ne Göre Over Kanseri Nedeniyle Ameliyat Olan Hastanın Hemşirelik Bakımı: Olgu Sunumu. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi; 2023. 6(3), 749-758. doi.org/10.38108/ouhcd.1217572
Islami F, Guerra CE, Minihan A, et al. American Cancer Society's report on the status of cancer disparities in the United States, 2021. CA: a cancer journal for clinicians; 2022.72(2), 112-143. doi.org/10.3322/caac.21703
Nalbantoğlu HG, Arslan P. Servikal kanser: Genel bakış. Karatekin University Journal of Science; 2023. 2(1), 43-50.
Grau-Bejar JF, Garcia-Duran C, Garcia-Illescas D, et al. (). Advances in immunotherapy for cervical cancer. Therapeutic Advances in Medical Oncology; 2023.15, doi.org/10.1177/175883592311638
Szymonowicz KA, Chen J. Biological and clinical aspects of HPV-related cancers. Cancer biology & medicine;2020.17(4), 864.
Aydoğdu SGM, Özsoy Ü. Serviks kanseri ve HPV. Androl Bul; 2018.(20):25−29.
Aref‐Adib M, Freeman‐Wang T. Cervical cancer prevention and screening: the role of human papillomavirus testing. Obstetrician & Gynaecologist; 2016.18(4). doi.org/10.1111/tog.12279
Avcı G, Bozdayı G. İnsan papilloma virüsü. Kafkas J Med Sci;2013. 3:136–44. doi.org/10.5505/kjms.2013.52724
Uyan DD, Başer DA, Sarı E, et al. Tıp fakültesi öğrencilerinin servikal kanser hakkında bilgi düzeyleri ve Human Papilloma Virus aşısına karşı tutumları. The Journal of Turkish Family Physician, 2021.12(2), 66-75.doi: 10.15511/tjtfp.21.00266
Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. The lancet global health; 2023.11(2), e197-e206. doi.org/10.1016/S2214-109X(22)00501-0
Rahangdale L, Mungo C, O’Connor S, Chibwesha CJ, et al. Human papillomavirus vaccination and cervical cancer risk. Bmj; 2022. 379. doi.org/10.1136/bmj-2022-070115
Eryılmaz G. Preinvaziv Serviks Kanseri. In: Yıldırım G (ed.) Jinekolojik Kanserler Güncel Konular ve Bakım. Ankara Nobel Tıp Kitabevleri: 2023; p172-174
Deo SVS, Sharma J, Kumar S. GLOBOCAN 2020 report on global cancer burden: challenges and opportunities for surgical oncologists. Annals of surgical oncology; 2022.29(11), 6497-6500. doi.org/10.1245/s10434-022-12151-6
Diniz ND, Rezende, MT, Bianchi, AGC, et al. A deep learning ensemble method to assist cytopathologists in pap test image classification. Journal of Imaging, 2021, 7.7: 111. doi.org/10.3390/jimaging7070111
Bedell SL, Goldstein LS, Goldstein AR, et al. Cervical cancer screening: past, present, and future. Sexual medicine reviews; 2020. 8(1), 28-37 doi.org/10.1016/j.sxmr.2019.09.005
Dede M. Profilaktik HPV aşıları: güncel yaklaşımlar. Gülhane Tıp Dergisi;2010. 52(2), 148-56.
Ngoma M, Autier P. Cancer prevention: cervical cancer. Ecancermedicalscience; 2019. 13. doi: 10.3332/ecancer.2019.952
Yang J, Delara R, Magrina J, et al. Management and outcomes of primary vaginal Cancer. Gynecologic oncology; 2020.159(2), 456-463. doi.org/10.1016/j.ygyno.2020.08.036
Yılmaz E, Coşkun Eİ, Taşkıran Ç. Gebelik ve Jinekolojik Kanserler. Türk Jinekolojik Onkoloji Dergisi; 2016.19(2), 19-28.
Adams TS, Rogers LJ, Cuello MA. (). Cancer of the vagina: 2021 update. International Journal of Gynecology & Obstetrics; 2021.155, 19-27. doi.org/10.1002/ijgo.13867
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians; 2018. 68(6), 394-424. https://doi.org/10.3322/caac.21492
Adams TS, Cuello MA. Cancer of the vagina. International Journal of Gynecology & Obstetrics; 2018. 143, 14-21. https://doi.org/10.1002/ijgo.12610
Adhikari P, Vietje P, Mount S. Premalignant and malignant lesions of the vagina. Diagn Histopathol; 2016.23:28-34. doi.org/10.1016/j.mpdhp.2016.11.006
Jhingran A. Updates in the treatment of vaginal cancer. International Journal of Gynecologic Cancer; 2022.32(3). doi.org/10.1136/ijgc-2021-002517
DeSantis C, Siegal R, Ma J, et al. Cancer treatment and survivorship statistics. American Cancer Society. CA Cancer J Clinic; 2018. 64, 252–27 https://doi.org/10.3322/caac.21235
Işık EG. PET/CT Imaging in Patients with Vulvar and Vaginal Cancer. Nukleer Tıp Seminerleri; 2022 8(3), 182. doi:10.4274/nts.galenos.2022.0021
Keskin HG, Tahta T. Vulva kanseri ve vulvektomi sonrası hemşirelik yaklaşımları. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 2021. 5(1), 115-121. doi.org/10.46237/amusbfd.725542
Alkatout I, Schubert M, Garbrecht N, et al. Vulvar cancer: epidemiology, clinical presentation, and management options. International journal of women's health; 2015. 305-313.
Şirin A. Kavlak O. Kadın Sağlığı (2nd ed.). İstanbul: Nobel Tıp Kitabevleri; 2015.
Tagliaferri L, Lancellotta V, Casà C, et al. The radiotherapy role in the multidisciplinary management of locally advanced vulvar cancer: a multidisciplinary VulCan team review. Cancers; 2021.13(22), 5747. doi.org/10.3390/cancers13225747
Rahm C, Adok C, Dahm-Kähler P, et al. Complications and risk factors in vulvar cancer surgery–A population-based study. European Journal of Surgical Oncology; 2022. 48(6), 1400-1406. doi.org/10.1016/j.ejso.2022.02.006
Demirtaş GS, Dinçer F, Görgülü G, et al. Prognostic factors in vulvar cancer patients: a single center experience. Pamukkale Medical Journal; 2021.14(4), 900-907. doi.org/10.31362/patd.978808
Aydın Ç, Göl M, Baloğlu A, e al. Vulva Kanseri Nedeniyle Radikal Vulvektomi Uygulanan Hastalarin Değerlendirilmesi. Ege Tıp Dergisi; 2002. 41(3), 147-150.
Agabekova B, Özler NB, Luboteni R. HPV İlişkili Kanserlere Karşı Mücdelede HPV Aşıları Hakkında Derleme. Turkey Health Literacy Journal; 2021.2(2), 89-98. Doi:10.54247/SOYD.2021.29
Akalın A. Human Papillomavirus (HPV) Enfeksiyonu ve HPV aşısında güncel yaklaşımlar. Androloji Bülteni; 2022. 24(2). doi.org/10.24898/tandro.2022.25993
Dursun P, Kaya D, Kuscu E, et al. Tubal Transizyonel Hücreli Karsinom. Türk Jinekolojik Onkoloji Dergisi;2007. 10(1), 26-28.
Suh MJ, Lee S, H, Kım et al. A case of primary tubal cancer evaluated with laparoscopy. Korean Journal of Obstetrics and Gynecology;2006. 1364-1370.
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2024. Available from: https://gco.iarc.who.int/today, accessed [15 Nisan 2024]
Berek JS, Matias‐Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. International Journal of Gynecology & Obstetrics;2023. 162(2), 383-394. https://doi.org/10.1002/ijgo.14923
